Literature DB >> 27194690

Multicenter Evaluation of Meridian Bioscience HSV 1&2 Molecular Assay for Detection of Herpes Simplex Virus 1 and 2 from Clinical Cutaneous and Mucocutaneous Specimens.

Matthew L Faron1, Nathan A Ledeboer2, Anami Patel3, Safedin H Beqa4, Belinda Yen-Lieberman5, Debra Kohn5, Amy L Leber6, Donna Mayne7, William I Northern8, Blake W Buchan9.   

Abstract

Herpes simplex virus (HSV) causes acute and relapsing symptoms characterized by ulcerative lesions. Laboratory diagnosis of HSV in cutaneous or mucocutaneous lesions has historically been performed with the use of viral cell culture systems; however, these tests are laborious and suffer decreased sensitivity for advanced-stage lesions. The recent availability of FDA-cleared moderately complex assays has resulted in the increased use of molecular diagnostics for the routine detection of HSV in superficial swab specimens. We performed a clinical evaluation of the recently FDA-cleared illumigene HSV 1&2 loop-mediated isothermal amplification (LAMP) assay (Meridian Bioscience, Cincinnati OH) for the detection and differentiation of HSV-1 and HSV-2 in cutaneous and mucocutaneous swab specimens. A total of 1,153 clinical swab specimens were collected and tested at 7 different clinical centers. Each specimen was tested for the presence of HSV-1 and HSV-2 using the illumigene assay, and results were compared to those of the enzyme-linked virus-inducible system (ELVIS) as the reference method. Overall, the illumigene assay demonstrated a sensitivity and specificity of 94.8% and 95.5%, respectively, for the detection of HSV-1. Detection of HSV-2 was similar, with a sensitivity of 98.9% and a specificity of 95.5%. Discrepant analysis was performed using an alternative molecular test (AmpliVue HSV1+2 assay; Quidel Molecular, San Diego, CA) on 91/99 specimens that were recorded as false positive (FP) or false negative (FN) compared to the reference method. In total, 57/78 (73%) FP and 9/13 (69%) FN illumigene results were supported by the AmpliVue result. The illumigene HSV 1&2 assay demonstrated high sensitivity and specificity to detect and differentiate HSV in clinical specimens and identified 57 additional specimens that were positive for HSV compared to culture. The use of LAMP eliminates the need for the cycling of temperatures and provides results in less than 60 min, with approximately 2 min of hands-on time per specimen.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27194690      PMCID: PMC4963491          DOI: 10.1128/JCM.00483-16

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Evaluation of the ELVIS plate method for the detection and typing of herpes simplex virus in clinical specimens.

Authors:  Gwen A Crist; Janine M Langer; Gail L Woods; Melinda Procter; David R Hillyard
Journal:  Diagn Microbiol Infect Dis       Date:  2004-07       Impact factor: 2.803

Review 2.  Herpes simplex virus infections.

Authors:  R J Whitley; B Roizman
Journal:  Lancet       Date:  2001-05-12       Impact factor: 79.321

3.  HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).

Authors:  Joann M Schulte; Abbie R Bellamy; Edward W Hook; David I Bernstein; Myron J Levin; Peter A Leone; Marcia L Sokol-Anderson; Marian G Ewell; Peter A Wolff; Thomas C Heineman; Robert B Belshe
Journal:  South Med J       Date:  2014-02       Impact factor: 0.954

Review 4.  Preventing herpes simplex virus in the newborn.

Authors:  Swetha G Pinninti; David W Kimberlin
Journal:  Clin Perinatol       Date:  2014-09-27       Impact factor: 3.430

5.  Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

Authors:  Fujie Xu; Maya R Sternberg; Benny J Kottiri; Geraldine M McQuillan; Francis K Lee; Andre J Nahmias; Stuart M Berman; Lauri E Markowitz
Journal:  JAMA       Date:  2006-08-23       Impact factor: 56.272

6.  Rapid detection of HSV with an enzyme-linked virus inducible system (ELVIS) employing a genetically modified cell line.

Authors:  M R Proffitt; S A Schindler
Journal:  Clin Diagn Virol       Date:  1995-08

7.  Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.

Authors:  Anna Wald; Meei-Li Huang; David Carrell; Stacy Selke; Lawrence Corey
Journal:  J Infect Dis       Date:  2003-10-31       Impact factor: 5.226

Review 8.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

9.  The diagnosis of genital herpes - beyond culture: An evidence-based guide for the utilization of polymerase chain reaction and herpes simplex virus type-specific serology.

Authors:  S Ratnam; A Severini; G Zahariadis; M Petric; B Romanowski
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

Review 10.  Current and future therapies for herpes simplex virus infections: mechanism of action and drug resistance.

Authors:  Scott H James; Mark N Prichard
Journal:  Curr Opin Virol       Date:  2014-07-16       Impact factor: 7.090

View more
  3 in total

Review 1.  Immune response of T cells during herpes simplex virus type 1 (HSV-1) infection.

Authors:  Jie Zhang; Huan Liu; Bin Wei
Journal:  J Zhejiang Univ Sci B       Date:  2017 Apr.       Impact factor: 3.066

Review 2.  Amplification chemistries in clinical virology.

Authors:  Sherry Dunbar; Shubhagata Das
Journal:  J Clin Virol       Date:  2019-03-27       Impact factor: 3.168

Review 3.  Current and Future Trends in the Laboratory Diagnosis of Sexually Transmitted Infections.

Authors:  Giorgia Caruso; Anna Giammanco; Roberta Virruso; Teresa Fasciana
Journal:  Int J Environ Res Public Health       Date:  2021-01-25       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.